Is heparin an acceptable anticoagulant when glycoprotein IIb/IIIa inhibitors are not used?

Michael S. Lee, Seung Woon Rha, Kyung Woo Park, Moo Hyun Kim

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)223-224
Number of pages2
JournalJACC: Cardiovascular Interventions
Issue number1
Publication statusPublished - 2015 Jan 1


  • Bivalirudin
  • Coronary artery disease
  • Heparin
  • Percutaneous coronary intervention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this